320 related articles for article (PubMed ID: 28858293)
1. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-Orbitrap, ADME prediction and network target analysis.
Guo R; Zhang X; Su J; Xu H; Zhang Y; Zhang F; Li D; Zhang Y; Xiao X; Ma S; Yang H
Phytomedicine; 2018 May; 44():117-128. PubMed ID: 29526583
[TBL] [Abstract][Full Text] [Related]
3. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.
Yu G; Zhang Y; Ren W; Dong L; Li J; Geng Y; Zhang Y; Li D; Xu H; Yang H
Int J Chron Obstruct Pulmon Dis; 2017; 12():85-94. PubMed ID: 28053519
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the pharmacological mechanism of the Chinese formula huanglian-jie-du decoction in the treatment of ischemic stroke using a systems biology-based strategy.
Zhang YQ; Wang SS; Zhu WL; Ma Y; Zhang FB; Liang RX; Xu HY; Yang HJ
Acta Pharmacol Sin; 2015 Jun; 36(6):724-33. PubMed ID: 25937634
[TBL] [Abstract][Full Text] [Related]
6. An integrated approach to uncover quality markers of Traditional Chinese medicine underlying chemical profiling, network target selection and metabolomics approach: Guan-Xin-Jing capsule as a model.
Zhang G; Wang Q; Liu X; Wang X; Xie W; Liu K; Jiang W; Mu C; Qi H; Wang Q
J Pharm Biomed Anal; 2020 Oct; 190():113413. PubMed ID: 32781322
[TBL] [Abstract][Full Text] [Related]
7. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
Yang J; Tian S; Zhao J; Zhang W
Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Xiong-Pi-Fang in treating coronary heart disease associated with depression: A systematic pharmacology strategy and in vivo pharmacological validation.
Deng F; Li X; Tang C; Chen J; Fan B; Liang J; Zhen X; Tao R; Zhang S; Cong Z; Du W; Zhao H; Xu L
J Ethnopharmacol; 2022 Nov; 298():115631. PubMed ID: 35987411
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.
Yu G; Wang W; Wang X; Xu M; Zhang L; Ding L; Guo R; Shi Y
BMC Complement Altern Med; 2018 Nov; 18(1):292. PubMed ID: 30382864
[TBL] [Abstract][Full Text] [Related]
10. Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach.
Haiyu X; Yang S; Yanqiong Z; Qiang J; Defeng L; Yi Z; Feng L; Hongjun Y
Mol Biosyst; 2016 Jan; 12(1):233-45. PubMed ID: 26588440
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.
Sheng S; Yang ZX; Xu FQ; Huang Y
Chin J Integr Med; 2021 Feb; 27(2):106-114. PubMed ID: 32388823
[TBL] [Abstract][Full Text] [Related]
12. Deciphering the therapeutic mechanisms of Xiao-Ke-An in treatment of type 2 diabetes in mice by a Fangjiomics approach.
Yang ZZ; Liu W; Zhang F; Li Z; Cheng YY
Acta Pharmacol Sin; 2015 Jun; 36(6):699-707. PubMed ID: 25960133
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment.
Lu C; Fu W; Zhou R; Hu W
BMC Complement Med Ther; 2020 Feb; 20(1):37. PubMed ID: 32024508
[TBL] [Abstract][Full Text] [Related]
14. The Therapeutical Effect of Chinese Medicine for the Treatment of Atherosclerotic Coronary Heart Disease.
Zhang J; Meng H; Zhang Y; Zhang X; Shao M; Li C; Tu P
Curr Pharm Des; 2017; 23(34):5086-5096. PubMed ID: 28782475
[TBL] [Abstract][Full Text] [Related]
15. A Systems Biology-Based Approach to Uncovering Molecular Mechanisms Underlying Effects of Traditional Chinese Medicine Qingdai in Chronic Myelogenous Leukemia, Involving Integration of Network Pharmacology and Molecular Docking Technology.
Zhou C; Liu L; Zhuang J; Wei J; Zhang T; Gao C; Liu C; Li H; Si H; Sun C
Med Sci Monit; 2018 Jun; 24():4305-4316. PubMed ID: 29934492
[TBL] [Abstract][Full Text] [Related]
16. Plasma metabolomics-based reveals the treatment mechanism of ShenGui capsule for application to coronary heart disease in a rat model.
Wang D; Guo J; Liu T; Zhou X; Yang Z; Shi C; Wang W; Li R; Zhang Y; Junzhang ; Yan J; Zhu X; Li Y; Gong M; Cui Y; Wu X
Anal Biochem; 2022 Apr; 642():114480. PubMed ID: 34813769
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology-based prediction of the active ingredients and mechanism of Shen Gui capsule for application to coronary heart disease.
Wang D; Tian L; Shi C; Wei YX; Wang H; Liu TT; Gong M; Zhang YW; Yu RG; Wu XH
Comput Biol Med; 2020 Jul; 122():103825. PubMed ID: 32658730
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation.
Li W; Mao X; Wu H; Guo M; Su X; Lu J; Guo Q; Li T; Wang X; Su W; Zhang Y; Lin N
Phytomedicine; 2020 Feb; 67():153156. PubMed ID: 31901568
[TBL] [Abstract][Full Text] [Related]
19. Molecular network-based analysis of guizhi-shaoyao-zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy.
Zhao N; Li J; Li L; Niu XY; Jiang M; He XJ; Bian ZX; Zhang G; Lu AP
Acta Pharmacol Sin; 2015 Jun; 36(6):716-23. PubMed ID: 25948477
[TBL] [Abstract][Full Text] [Related]
20. Systematically characterized mechanism of treatment for lumbar disc herniation based on Yaobitong capsule ingredient analysis in rat plasma and its network pharmacology strategy by UPLC-MS/MS.
Deng Y; Gao X; Feng T; Wang Z; Xiao W; Xiong Z; Zhao L
J Ethnopharmacol; 2020 Oct; 260():113097. PubMed ID: 32531413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
